The Talent Pool - The weather might leave something to be desired, but it would take more than the occasional shower to stem the flow of talent into Scotland. - BioPharm International

ADVERTISEMENT

The Talent Pool
The weather might leave something to be desired, but it would take more than the occasional shower to stem the flow of talent into Scotland.

BioPharm International


Professor Dominiczak believes strongly in the interconnectivity of scientific research. She feels strongly that one of the advantages of the active life sciences community in the West of Scotland is the opportunity available to all to draw together the threads of many different research projects.

"Regardless of technology, life-changing discoveries are often made while chatting over a cup of coffee," she says. "The friendly environment surrounding the new center greatly facilitates both the formal and informal sharing of knowledge."

Professor Walter Kolch


Kolch
Professor of Biomedical and Life Sciences at the University of Glasgow and group leader at the Beatson Institute, Glasgow, Professor Walter Kolch has a world-class reputation for his research in proteomics, cell signaling, and analytical biochemistry. His work centers on the principles of cancer growth and transformation and, in particular, of signal transduction pathways, or intercellular channels of communication.

Born and educated in Austria, Professor Kolch worked extensively in both the US and Germany before moving to the Beatson Institute for Cancer Research ( http://www.beatson.gla.ac.uk/) in Glasgow in 1998. He was appointed Professor of Molecular Cell Biology at the University of Glasgow in 2000.

Professor Kolch is also a highly successful manager of research projects and was the lead applicant in the successful funding application, which led to the establishment of the Sir Henry Wellcome Functional Genomics Facility (SHWFGF) at the University of Glasgow in 2001.

Professor Kolch points out that an essential part of scientific research is teamwork. His base in the West of Scotland places him at the forefront of biochemistry and signal transduction research/proteomics in Europe.

Not least among the advantages he finds here is the approximately $21-million grant made in 2005 by the Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council—two of the most important granting institutions in the UK—for the development of proteomics technologies over a six-year period. This is a joint project involving researchers from three Scottish universities in Glasgow, Edinburgh, and Dundee.


blog comments powered by Disqus

ADVERTISEMENT

Moscow Hosts IFPMA Biosimilars Conference
May 17, 2013
AbbVie and Alvine Will Collaborate on Celiac Disease Therapy
May 15, 2013
FDA Issues Pharmacoepidemiologic Safety Study Guidance
May 14, 2013
USP Launches Initiative to Fight Counterfeit Drugs in Sub-Saharan Africa
May 13, 2013
Amgen Forms New Joint Venture to Commercialize Vectibix in China
May 13, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International,
Click here